ReviewFrontiers in oncology2021

Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma.

Shansa Pranami E Jayaweera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.